Physician Search

Consuelo Wilkins, MD, MSCI, Senior Vice President for Health Equity and Inclusive Excellence for Vanderbilt University Medical Center (VUMC) and Senior Associate Dean for Health Equity and Inclusive Excellence for Vanderbilt University School of Medicine, always knew she wanted to be a physician. "Health equity was built into everything I did, even if I didn’t know it or recognize it at the time," Wilkins said. "I have always learned and believed that people are the same — everyone deserves to be healthy, and everyone should have the best opportunities to take care of themselves and their families." Click below to learn more about health equity initiatives.

https://momentum.vicc.org/2021/09/everyone-deserves-to-be-healthy/

Vanderbilt was the lead site for an NIH-funded, phase 2, multicenter influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant (HCT) recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population. Natasha Halasa, MD, MPH and colleagues recently published in the New England Journal of Medicine, that two doses of high-dose trivalent flu vaccine resulted in higher amounts of influenza-specific antibodies than two doses of standard dose quadrivalent vaccine.

https://news.vumc.org/2023/03/02/high-dose-flu-vaccine-beneficial-for-pediatric-stem-cell-transplant-patients/

Filter By:
Search by Keyword:

Displaying 11 - 20 of 323

Prospective Observational Trial of an Absorbable Hydrogel Spacer in Prostate Cancer Radiotherapy

Prostate

Disease Sites: Prostate

Phase: N/A

Investigator: Kirschner, Austin

NCTID:

Protocol No: VICCURO16112

Ocular Tumor Tissue Acquisition to Study Biologic Correlates of Disease

Multiple Cancer Types

Disease Sites: Pediatrics, Retinoblastoma (Pediatrics)

Phase: N/A

Investigator: Daniels, Anthony

NCTID:

Protocol No: VICCPED16115

Using Biomarkers and Imaging in Fungal Regions to Improve Lung Cancer Diagnosis

Lung

Disease Sites: Lung

Phase: N/A

Investigator: Grogan, Eric

NCTID:

Protocol No: VICCTHO1764

Chemotherapy Levels in the Blood of Patients with Retinoblastoma

Retinoblastoma (Pediatrics)

Disease Sites: Retinoblastoma (Pediatrics)

Phase: N/A

Investigator: Daniels, Anthony

NCTID:

Protocol No: VICCREACH1792

Chemotherapy Levels in the Eyes of Patients with Retinoblastoma

Retinoblastoma (Pediatrics)

Disease Sites: Retinoblastoma (Pediatrics)

Phase: N/A

Investigator: Daniels, Anthony

NCTID:

Protocol No: VICCREACH17106

Developing Evidence-Based Criteria for Initiating Treatment for Neurofibromatosis Type 1 Associated Optic Pathway Glioma

Multiple Cancer Types

Disease Sites: Neuro-Oncology, Pediatrics

Phase: N/A

Investigator: Esbenshade, Adam

NCTID:

Protocol No: VICCPED17108

Optimization of Cancer Therapy Using Immune Effector Cells

Hematologic

Disease Sites: Hematologic

Phase: N/A

Investigator: Oluwole, Olalekan

NCTID:

Protocol No: VICCCTT1834

Integrating Comprehensive Precision Tobacco Treatment for Patients with Cancer

Miscellaneous

Disease Sites: Miscellaneous

Phase: N/A

Investigator: Tindle, Hilary

NCTID:

Protocol No: VICCTHO1886

Nashville Biosciences Blood Sample Collection Study

Multiple Cancer Types

Disease Sites: Colon, Liver, Lung, Non Small Cell, Ovarian, Pancreatic, Rectal

Phase: N/A

Investigator: Bernard, Gordon

NCTID:

Protocol No: VICCMD18123

Cancer Patient Safety Learning Laboratory (CaPSLL): Preventing Clinical Deterioration in Outpatients

Multiple Cancer Types

Disease Sites: Head/Neck, Lung

Phase: N/A

Investigator: Weinger, Matthew

NCTID:

Protocol No: VICCMD1998